Global Meningococcal Vaccines Market Research Report 2021
- Published Date: 2021-05-14
- Report ID: 113064
- Pages: 150
-
Format:
Prudent Markets Predicts that Meningococcal Vaccines Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Meningococcal Vaccines Market Overview:
Global Meningococcal Vaccines Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Meningococcal Vaccines involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Meningococcal Vaccines Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Meningococcal Vaccines market in 2020.
Global Meningococcal Vaccines Market Segmentation
By Type, Meningococcal Vaccines market has been segmented into:
Menactra
Menomune
By Application, Meningococcal Vaccines market has been segmented into:
Pneumonia
Meningitis
Bacteremia
Others (Arthritis
Conjunctivitis
Urethritis)
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Meningococcal Vaccines market are:
GlaxoSmithKline
JN-International Medical
Novartis International
Sanofi
Pfizer
Baxter International
1. Market Overview of Meningococcal Vaccines
1.1 Meningococcal Vaccines Market Overview
1.1.1 Meningococcal Vaccines Product Scope
1.1.2 Market Status and Outlook
1.2 Meningococcal Vaccines Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Meningococcal Vaccines Historic Market Size by Regions (2015-2020)
1.4 Meningococcal Vaccines Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Meningococcal Vaccines Sales Market by Type (2015-2026)
2.1 Global Meningococcal Vaccines Historic Market Size by Type (2015-2020)
2.2 Global Meningococcal Vaccines Forecasted Market Size by Type (2021-2026)
2.3 Menactra
2.4 Menomune
3. Covid-19 Impact Meningococcal Vaccines Sales Market by Application (2015-2026)
3.1 Global Meningococcal Vaccines Historic Market Size by Application (2015-2020)
3.2 Global Meningococcal Vaccines Forecasted Market Size by Application (2021-2026)
3.3 Pneumonia
3.4 Meningitis
3.5 Bacteremia
3.6 Others (Arthritis
3.7 Conjunctivitis
3.8 Urethritis)
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Meningococcal Vaccines Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Meningococcal Vaccines Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Meningococcal Vaccines Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Meningococcal Vaccines Business
5.1 GlaxoSmithKline
5.1.1 GlaxoSmithKline Company Profile
5.1.2 GlaxoSmithKline Meningococcal Vaccines Product Specification
5.1.3 GlaxoSmithKline Meningococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 JN-International Medical
5.2.1 JN-International Medical Company Profile
5.2.2 JN-International Medical Meningococcal Vaccines Product Specification
5.2.3 JN-International Medical Meningococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Novartis International
5.3.1 Novartis International Company Profile
5.3.2 Novartis International Meningococcal Vaccines Product Specification
5.3.3 Novartis International Meningococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Sanofi
5.4.1 Sanofi Company Profile
5.4.2 Sanofi Meningococcal Vaccines Product Specification
5.4.3 Sanofi Meningococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Pfizer
5.5.1 Pfizer Company Profile
5.5.2 Pfizer Meningococcal Vaccines Product Specification
5.5.3 Pfizer Meningococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Baxter International
5.6.1 Baxter International Company Profile
5.6.2 Baxter International Meningococcal Vaccines Product Specification
5.6.3 Baxter International Meningococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Meningococcal Vaccines Market Size (2015-2026)
6.2 North America Meningococcal Vaccines Key Players in North America (2015-2020)
6.3 North America Meningococcal Vaccines Market Size by Type (2015-2020)
6.4 North America Meningococcal Vaccines Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Meningococcal Vaccines Market Size (2015-2026)
7.2 East Asia Meningococcal Vaccines Key Players in North America (2015-2020)
7.3 East Asia Meningococcal Vaccines Market Size by Type (2015-2020)
7.4 East Asia Meningococcal Vaccines Market Size by Application (2015-2020)
8. Europe
8.1 Europe Meningococcal Vaccines Market Size (2015-2026)
8.2 Europe Meningococcal Vaccines Key Players in North America (2015-2020)
8.3 Europe Meningococcal Vaccines Market Size by Type (2015-2020)
8.4 Europe Meningococcal Vaccines Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Meningococcal Vaccines Market Size (2015-2026)
9.2 South Asia Meningococcal Vaccines Key Players in North America (2015-2020)
9.3 South Asia Meningococcal Vaccines Market Size by Type (2015-2020)
9.4 South Asia Meningococcal Vaccines Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Meningococcal Vaccines Market Size (2015-2026)
10.2 Southeast Asia Meningococcal Vaccines Key Players in North America (2015-2020)
10.3 Southeast Asia Meningococcal Vaccines Market Size by Type (2015-2020)
10.4 Southeast Asia Meningococcal Vaccines Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Meningococcal Vaccines Market Size (2015-2026)
11.2 Middle East Meningococcal Vaccines Key Players in North America (2015-2020)
11.3 Middle East Meningococcal Vaccines Market Size by Type (2015-2020)
11.4 Middle East Meningococcal Vaccines Market Size by Application (2015-2020)
12. Africa
12.1 Africa Meningococcal Vaccines Market Size (2015-2026)
12.2 Africa Meningococcal Vaccines Key Players in North America (2015-2020)
12.3 Africa Meningococcal Vaccines Market Size by Type (2015-2020)
12.4 Africa Meningococcal Vaccines Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Meningococcal Vaccines Market Size (2015-2026)
13.2 Oceania Meningococcal Vaccines Key Players in North America (2015-2020)
13.3 Oceania Meningococcal Vaccines Market Size by Type (2015-2020)
13.4 Oceania Meningococcal Vaccines Market Size by Application (2015-2020)
14. South America
14.1 South America Meningococcal Vaccines Market Size (2015-2026)
14.2 South America Meningococcal Vaccines Key Players in North America (2015-2020)
14.3 South America Meningococcal Vaccines Market Size by Type (2015-2020)
14.4 South America Meningococcal Vaccines Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Meningococcal Vaccines Market Size (2015-2026)
15.2 Rest of the World Meningococcal Vaccines Key Players in North America (2015-2020)
15.3 Rest of the World Meningococcal Vaccines Market Size by Type (2015-2020)
15.4 Rest of the World Meningococcal Vaccines Market Size by Application (2015-2020)
16 Meningococcal Vaccines Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porters Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
